Overview
Trisomy 18 syndrome, also known as Edwards syndrome, is a chromosomal disorder caused by the presence of an extra copy of chromosome 18. It is the second most common autosomal trisomy after Down syndrome (trisomy 21). The condition can occur as full trisomy 18 (most common, accounting for approximately 94% of cases), mosaic trisomy 18, or partial trisomy 18. The ICD-10 codes reflect these subtypes: Q91.0 and Q91.1 for full trisomy 18 (nondisjunction and mosaicism, respectively), Q91.2 for translocation forms, and Q91.3 for unspecified trisomy 18. Trisomy 18 affects virtually every organ system in the body. Key clinical features include severe intrauterine growth restriction, a distinctive craniofacial appearance with a prominent occiput, micrognathia (small jaw), and low-set malformed ears. Characteristic hand positioning with overlapping fingers (clenched fists with the index finger overlapping the third and the fifth finger overlapping the fourth) is a hallmark finding. Congenital heart defects are present in over 90% of affected individuals, most commonly ventricular septal defects and polyvalvular disease. Other features include rocker-bottom feet, short sternum, renal malformations, omphalocele, and severe intellectual disability. Many affected pregnancies result in miscarriage or stillbirth. The prognosis for full trisomy 18 is very poor, with median survival of approximately 5 to 15 days. Approximately 50% of affected infants do not survive beyond the first week of life, and only 5–10% survive beyond the first year. Individuals with mosaic trisomy 18 may have a milder phenotype and longer survival. There is no cure for trisomy 18. Management is supportive and individualized, focusing on comfort care, nutritional support, and treatment of specific complications such as cardiac defects when appropriate. Palliative care discussions are an important component of management. Advanced maternal age is a recognized risk factor, and prenatal diagnosis is possible through screening tests and confirmatory procedures such as amniocentesis or chorionic villus sampling.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Trisomy 18 syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Trisomy 18 syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Trisomy 18 syndrome.
Community
No community posts yet. Be the first to share your experience with Trisomy 18 syndrome.
Start the conversation →Latest news about Trisomy 18 syndrome
No recent news articles for Trisomy 18 syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Trisomy 18 syndrome
What is Trisomy 18 syndrome?
Trisomy 18 syndrome, also known as Edwards syndrome, is a chromosomal disorder caused by the presence of an extra copy of chromosome 18. It is the second most common autosomal trisomy after Down syndrome (trisomy 21). The condition can occur as full trisomy 18 (most common, accounting for approximately 94% of cases), mosaic trisomy 18, or partial trisomy 18. The ICD-10 codes reflect these subtypes: Q91.0 and Q91.1 for full trisomy 18 (nondisjunction and mosaicism, respectively), Q91.2 for translocation forms, and Q91.3 for unspecified trisomy 18. Trisomy 18 affects virtually every organ syste
How is Trisomy 18 syndrome inherited?
Trisomy 18 syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Trisomy 18 syndrome typically begin?
Typical onset of Trisomy 18 syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Trisomy 18 syndrome?
25 specialists and care centers treating Trisomy 18 syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.